Santhera Pharmaceuticals Holding AG (SANN.SW) SIX

12.60

-0.66(-4.98%)

Updated at January 15 05:30PM

Currency In CHF

Valuation

Market Cap157.2M
Enterprise Value157.45M
P/E Ratio-2.46
PEG Ratio0.05
Price/Sales Ratio3.44
Price/Book Ratio-62.83
Enterprise/Revenue4.62
Enterprise/EBITDA-6.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.34
Operating Margin-1.04

Management Effectiveness

Return On Assets-0.5
Return On Equity-5.22

Income Statement

Revenue39.12M
Revenue/Share3.84
Gross Profit22.96M
EBITDA-15.89M
Net Income-41.97M
Diluted EPS-3.69

Balance Sheet

Total Cash18.4M
Total Cash/Share1.44
Total Debt76.3M
Total Debt/Equity-29.77
Current Ratio1.02
Book Value Per Share-0.2

Price History

52-Week Change-10
52-Week High17.76
52-Week Low9.38
Moving Average 50 Days12.07
Moving Average 200 Days12.63

Statistics

Average Volume69,528
Shares Outstanding13.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 03, 2023